Analysts expect Stericycle Inc (NASDAQ:SRCL) to report earnings per share of $0.84 for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Stericycle’s earnings, with estimates ranging from $0.80 to $0.88. Stericycle reported earnings per share of $1.17 during the same quarter last year, which would suggest a negative year over year growth rate of 28.2%. The company is expected to report its next earnings results on Thursday, August 1st.
On average, analysts expect that Stericycle will report full-year earnings of $3.34 per share for the current financial year, with EPS estimates ranging from $3.19 to $3.53. For the next year, analysts expect that the company will post earnings of $3.92 per share, with EPS estimates ranging from $3.62 to $4.81. Zacks’ earnings per share averages are an average based on a survey of sell-side analysts that that provide coverage for Stericycle.
Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, February 28th. The business services provider reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.07. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%. The company had revenue of $852.70 million for the quarter, compared to the consensus estimate of $848.75 million.
SRCL has been the topic of a number of research analyst reports. BMO Capital Markets increased their target price on Stericycle from $41.00 to $45.00 and gave the stock a “market perform” rating in a report on Monday, March 4th. Robert W. Baird downgraded Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 target price on the stock. in a report on Wednesday, April 17th. Zacks Investment Research downgraded Stericycle from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 7th. Barrington Research reduced their target price on Stericycle from $64.00 to $55.00 and set an “outperform” rating on the stock in a report on Monday, March 11th. Finally, Goldman Sachs Group upgraded Stericycle from a “neutral” rating to a “buy” rating and set a $66.00 price target on the stock in a research report on Friday, March 1st. Four investment analysts have rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $59.00.
In other news, Director Mark C. Miller sold 260,314 shares of the business’s stock in a transaction on Tuesday, April 9th. The shares were sold at an average price of $57.18, for a total value of $14,884,754.52. Following the completion of the transaction, the director now owns 325,848 shares of the company’s stock, valued at approximately $18,631,988.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 2.30% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in SRCL. JOYN Advisors Inc. boosted its stake in Stericycle by 1,253.7% in the 4th quarter. JOYN Advisors Inc. now owns 731 shares of the business services provider’s stock worth $27,000 after purchasing an additional 677 shares during the period. Bronfman E.L. Rothschild L.P. boosted its stake in Stericycle by 159.5% in the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 807 shares of the business services provider’s stock worth $30,000 after purchasing an additional 496 shares during the period. Pearl River Capital LLC acquired a new position in Stericycle in the 4th quarter worth $41,000. Oregon Public Employees Retirement Fund boosted its stake in Stericycle by 6,998.9% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,638,209 shares of the business services provider’s stock worth $45,000 after purchasing an additional 1,615,132 shares during the period. Finally, Blue Sky Asset Management LLC acquired a new position in shares of Stericycle during the 1st quarter worth about $60,000. 96.52% of the stock is owned by hedge funds and other institutional investors.
NASDAQ:SRCL traded down $0.45 during trading hours on Tuesday, reaching $48.34. 454,788 shares of the stock were exchanged, compared to its average volume of 1,333,040. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 1.17. Stericycle has a 52 week low of $34.36 and a 52 week high of $71.43. The company has a market cap of $4.40 billion, a PE ratio of 10.86, a P/E/G ratio of 1.88 and a beta of 1.11.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Featured Article: Technical Analysis
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.